Elevated peripheral frequencies of th22 cells: A novel potent participant in obesity and type 2 diabetes

PLoS ONE

Volumn 9, Issue 1, 2014, Pages

  Zhao, Ruxing ^a,b   Tang, Dongqi ^a   Yi, Shounan ^c   Li, Wenjuan ^a   Wu, Chuanlong ^a   Lu, Yiran ^a   Hou, Xinguo ^a   Song, Jun ^a   Lin, Peng ^a   Chen, Li ^a,b   Sun, Lei ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22;

ADULT; ARTICLE; BODY MASS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; INSULIN RESISTANCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; PROTEIN BLOOD LEVEL; TH1 CELL; TH17 CELL; TH22 CELL;

ADULT; CASE-CONTROL STUDIES; CELL POLARITY; DEMOGRAPHY; DIABETES MELLITUS, TYPE 2; FEMALE; FLOW CYTOMETRY; HUMANS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; INTERFERON-GAMMA; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKINS; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; OBESITY; PHENOTYPE; PREVALENCE; T-LYMPHOCYTES, HELPER-INDUCER; TH1 CELLS; TH17 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84898465181     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0085770     Document Type: Article

References (42)

1. Flier JS (2004) Obesity wars: molecular progress confronts an expanding epidemic. Cell 116: 337-350.
2. Prentki M, Nolan CJ (2006) Islet beta cell failure in type 2 diabetes. J Clin Invest 116: 1802-1812. (Pubitemid 44033300)
3. Hotamisligil GS (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
4. Festa A, D'Agostino R, Jr., Williams K, Karter AJ, Mayer-Davis EJ, et al. (2001) The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord 25: 1407-1415. (Pubitemid 32977855)
5. Xu H, Barnes GT, Yang Q, Tan G, Yang D, et al. (2003) Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 112: 1821-1830. (Pubitemid 38063705)
6. Boulet LP (2008) Influence of obesity on the prevalence and clinical features of asthma. Clin Invest Med 31: E386-390.
7. Hannan MT (2013) Introduction to special theme section: obesity and the rheumatic diseases. Arthritis Care Res (Hoboken) 65: 4.
8. Fink C, Karagiannides I, Bakirtzi K, Pothoulakis C (2012) Adipose tissue and inflammatory bowel disease pathogenesis. Inflamm Bowel Dis 18: 1550-1557.
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, et al. (2003) Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 112: 1796-1808. (Pubitemid 38063703)
10. Lumeng CN, Bodzin JL, Saltiel AR (2007) Obesity induces a phenotypic switch in adipose tissue macrophage polarization. J Clin Invest 117: 175-184. (Pubitemid 46048464)
11. Wu H, Ghosh S, Perrard XD, Feng L, Garcia GE, et al. (2007) T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 115: 1029-1038. (Pubitemid 46328297)
12. Kintscher U, Hartge M, Hess K, Foryst-Ludwig A, Clemenz M, et al. (2008) T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28: 1304-1310.
13. Nishimura S, Manabe I, Nagasaki M, Eto K, Yamashita H, et al. (2009) CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat Med 15: 914-920.
14. Winer S, Chan Y, Paltser G, Truong D, Tsui H, et al. (2009) Normalization of obesity-associated insulin resistance through immunotherapy. Nat Med 15: 921-929.
15. Feuerer M, Herrero L, Cipolletta D, Naaz A, Wong J, et al. (2009) Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat Med 15: 930-939.
16. Jagannathan-Bogdan M, McDonnell ME, Shin H, Rehman Q, Hasturk H, et al. (2011) Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J Immunol 186: 1162-1172.
17. Zeng C, Shi X, Zhang B, Liu H, Zhang L, et al. (2012) The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J Mol Med (Berl) 90: 175-186.
18. Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009) Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol 10: 864-871.
19. Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, et al. (2009) Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119: 3573-3585.
20. Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, et al. (2010) Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 40: 2450-2459.
21. Zenewicz LA, Flavell RA (2008) IL-22 and inflammation: leukin' through a glass onion. Eur J Immunol 38: 3265-3268.
22. Zhang L, Li YG, Li YH, Qi L, Liu XG, et al. (2012) Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PLoS One 7: e31000.
23. Hu Y, Li H, Zhang L, Shan B, Xu X, et al. (2012) Elevated profiles of Th22 cells and correlations with Th17 cells in patients with immune thrombocytopenia. Hum Immunol 73: 629-635.
24. Zhang N, Pan HF, Ye DQ (2011) Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Mol Cell Biochem 353: 41-46.
25. Peng D, Xu B, Wang Y, Guo H, Jiang Y (2013) A high frequency of circulating th22 and th17 cells in patients with new onset graves' disease. PLoS One 8: e68446.
26. Haffner SM, Miettinen H, Stern MP (1997) The homeostasis model in the San Antonio Heart Study. Diabetes Care 20: 1087-1092. (Pubitemid 27274268)
27. Habib SL, Rojna M (2013) Diabetes and risk of cancer. ISRN Oncol 2013: 583786.
28. Tian T, Yu S, Ma D (2013) Th22 and related cytokines in inflammatory and autoimmune diseases. Expert Opin Ther Targets 17: 113-125.
29. Shao LL, Zhang L, Hou Y, Yu S, Liu XG, et al. (2012) Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome. PLoS One 7: e51339.
30. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009) Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857-863.
31. Kang HJ, Seo HA, Go Y, Oh CJ, Jeoung NH, et al. (2013) Dimethylfumarate suppresses adipogenic differentiation in 3T3-L1 preadipocytes through inhibition of STAT3 activity. PLoS One 8: e61411.
32. Mashili F, Chibalin AV, Krook A, Zierath JR (2013) Constitutive STAT3 phosphorylation contributes to skeletal muscle insulin resistance in type 2 diabetes. Diabetes 62: 457-465.
33. Wunderlich CM, Hovelmeyer N, Wunderlich FT (2013) Mechanisms of chronic JAK-STAT3-SOCS3 signaling in obesity. JAKSTAT 2: e23878.
34. Moller DE (2000) Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes. Trends Endocrinol Metab 11: 212-217. (Pubitemid 30603166)
35. Katsuki A, Sumida Y, Murashima S, Murata K, Takarada Y, et al. (1998) Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83: 859-862. (Pubitemid 28496458)
36. Panagiotakos DB, Pitsavos C, Yannakoulia M, Chrysohoou C, Stefanadis C (2005) The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study. Atherosclerosis 183: 308-315. (Pubitemid 41579282)
37. Stephens JM, Lee J, Pilch PF (1997) Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction. J Biol Chem 272: 971-976. (Pubitemid 27034588)
38. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS (1997) Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function. Nature 389: 610-614. (Pubitemid 27446179)
39. Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG (1999) Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus. J Clin Endocrinol Metab 84: 272-278. (Pubitemid 29036713)
40. Ortis F, Pirot P, Naamane N, Kreins AY, Rasschaert J, et al. (2008) Induction of nuclear factor-kappaB and its downstream genes by TNF-alpha and IL-1beta has a pro-apoptotic role in pancreatic beta cells. Diabetologia 51: 1213-1225.
41. Carbo A, Hontecillas R, Kronsteiner B, Viladomiu M, Pedragosa M, et al. (2013) Systems modeling of molecular mechanisms controlling cytokine-driven CD4+ T cell differentiation and phenotype plasticity. PLoS Comput Biol 9: e1003027.
42. Tang T, Zhang J, Yin J, Staszkiewicz J, Gawronska-Kozak B, et al. (2010) Uncoupling of inflammation and insulin resistance by NF-kappaB in transgenic mice through elevated energy expenditure. J Biol Chem 285: 4637-4644.